Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort

Keyphrases

• Clinical Characteristics 14%
• CLK1 42%
• Complement Lectin Pathway 100%
• Denmark 14%
• Disease Activity 100%
• Disease Course 14%
• Disease Onset 57%
• Finland 14%
• H-ficolin 14%
• High Disease Activity 14%
• Inflammation Markers 14%
• Lectin Pathway 28%
• Lectin Protein 14%
• Low ESR 14%
• M-ficolin 57%
• MASP-1 42%
• MASP-3 42%
• Norway 14%
• Population-based 14%
• Population-based Cohort Study 14%
• Predictive Value 14%
• Prognostic Ability 14%
• Protein Level 100%
• Remission Status 28%
• Serum Levels 14%
• Sweden 14%
• Systemic Juvenile Idiopathic Arthritis (sJIA) 100%

Immunology and Microbiology

• Blood Level 14%
• Complement Lectin Pathway 100%
• Ficolin 71%
• Juvenile Idiopathic Arthritis 100%
• Lectin 14%
• Lectin Pathway 28%